Abstract
Introduction: Endothelial progenitor cells (EPC) were shown to be involved in vascular regeneration and angiogenesis in experimental diabetes. EPC of patients with both diabetes type 1 and type 2 demonstrate impaired outgrowth and function. In previous studies it was shown, that insulin increases in vitro proliferation of EPC isolated from healthy volunteers. Since clinical studies indicate that insulin therapy enhances the number of circulating CD34+/CD133+ cells in type 2 diabetes patients, we studied effects of human insulin on in vitro outgrowth of EPC isolated from type 2 diabetes patients and receptors mediating these effects.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call